Company intelligence / Profile preview

Ception Therapeutics

Malvern, Pennsylvania, United Statesprnewswire.com ↗

Ownership: Private
Employees: ~6
Development stage: Phase 1

Overview

Ception’s lead product, reslizumab—a humanized monoclonal antibody targeting IL‑5—reached Phase IIb/III clinical trials for pediatric eosinophilic esophagitis and was also studied in adult eosinophilic asthma. The FDA granted orphan drug status to reslizumab for pediatric EE. Clinical results showed promise in reducing symptoms and inflammation associated with EE, supporting potential regulatory filings.[6][8] The company also developed an orally available small molecule anti-TNF agent and had a preclinical/early-stage antibiotic program targeting β-lactamase.[5]

Therapeutic areas: GastroenterologyPulmonologyInfectious Diseases
Modalities: Monoclonal antibodies (mAbs)Small molecules[6][8][10]
Industry: Biotech

Drug pipeline

1 asset

reslizumab

Phase 1

Indications: Inflammatory conditions

Partnerships

Cephalon, Inc.—option agreement leading to full acquisition for $250 million plus milestones.[10] No other major partnerships disclosed.

Beyond the preview

Go deeper on Ception Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ception Therapeutics.

Explore the full profile